Myomo (MYO) Short term Debt (2017 - 2025)
Myomo posted quarterly Short term Debt of $2.7 million for Q4 2025, up 368.56% on a QoQ basis from $583333.0 in Q3 2025.
Myomo (MYO) has 5 years of Short term Debt data on file, last reported at $2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (changed N/A YoY), and the FY2025 full-year result was $2.7 million, changed N/A from the prior year.
- Short term Debt for Q4 2025 stood at $2.7 million, up from $583333.0 in the prior quarter.
- Across five years, Short term Debt topped out at $2.7 million in Q4 2025 and bottomed at $583333.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.73 Mn |
| Sep 30, 2025 | 583,333.00 |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2020 | 888.00 |
| Mar 31, 2020 | 1.43 Mn |
| Dec 31, 2019 | 378,239.00 |
| Sep 30, 2019 | 43,942.00 |
| Jun 30, 2019 | 58,477.00 |
| Mar 31, 2019 | 157,927.00 |
| Dec 31, 2018 | 3,661.00 |
| Sep 30, 2018 | 8,652.00 |
| Jun 30, 2018 | 21,962.00 |
| Mar 31, 2018 | 24,623.00 |
| Dec 31, 2017 | 39,930.00 |
| Sep 30, 2017 | 92,359.00 |